nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CYP3A4—Calcitriol—psoriasis	0.115	0.191	CbGbCtD
Phenoxybenzamine—CYP3A4—Methoxsalen—psoriasis	0.0892	0.149	CbGbCtD
Phenoxybenzamine—CYP3A4—Cholecalciferol—psoriasis	0.0591	0.0986	CbGbCtD
Phenoxybenzamine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0512	0.0855	CbGbCtD
Phenoxybenzamine—CYP3A4—Triamcinolone—psoriasis	0.0512	0.0855	CbGbCtD
Phenoxybenzamine—CYP3A4—Betamethasone—psoriasis	0.044	0.0734	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisolone—psoriasis	0.0434	0.0724	CbGbCtD
Phenoxybenzamine—CYP3A4—Hydrocortisone—psoriasis	0.0411	0.0686	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisone—psoriasis	0.041	0.0684	CbGbCtD
Phenoxybenzamine—CYP3A4—Cyclosporine—psoriasis	0.0388	0.0648	CbGbCtD
Phenoxybenzamine—CYP3A4—Dexamethasone—psoriasis	0.0256	0.0427	CbGbCtD
Phenoxybenzamine—ADRA2B—Hemostasis—TP53—psoriasis	0.000114	0.000285	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-B—psoriasis	0.000114	0.000284	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-B—psoriasis	0.000114	0.000284	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	0.000113	0.000282	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD4—psoriasis	0.000112	0.00028	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD4—psoriasis	0.000112	0.00028	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CAT—psoriasis	0.000111	0.000277	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—IL6—psoriasis	0.000111	0.000276	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—IL6—psoriasis	0.000111	0.000276	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	0.00011	0.000275	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—APOE—psoriasis	0.000109	0.000272	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-A—psoriasis	0.000109	0.000272	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	0.000108	0.00027	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—JUN—psoriasis	0.000108	0.000269	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	0.000107	0.000267	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TP53—psoriasis	0.000107	0.000267	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—APOE—psoriasis	0.000106	0.000265	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CXCL8—psoriasis	0.000106	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-A—psoriasis	0.000106	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-A—psoriasis	0.000106	0.000263	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—APOE—psoriasis	0.000105	0.000263	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—LEP—psoriasis	0.000105	0.000263	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	0.000105	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—VEGFA—psoriasis	0.000105	0.000261	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—JUN—psoriasis	0.000105	0.000261	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—JUN—psoriasis	0.000105	0.000261	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CRP—psoriasis	0.000104	0.00026	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—NFKB1—psoriasis	0.000104	0.000259	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—APOE—psoriasis	0.000102	0.000254	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—VEGFA—psoriasis	0.000101	0.000253	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—VEGFA—psoriasis	0.000101	0.000253	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CAT—psoriasis	0.000101	0.000253	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HLA-A—psoriasis	0.000101	0.000251	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CRP—psoriasis	0.000101	0.000251	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CRP—psoriasis	0.000101	0.000251	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—NFKB1—psoriasis	0.000101	0.000251	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—NFKB1—psoriasis	0.000101	0.000251	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	0.0001	0.00025	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	0.0001	0.000249	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—NFKB1—psoriasis	9.99e-05	0.000249	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-DRB1—psoriasis	9.97e-05	0.000249	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	9.84e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	9.82e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CAT—psoriasis	9.8e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CAT—psoriasis	9.8e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	9.78e-05	0.000244	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HLA-A—psoriasis	9.74e-05	0.000243	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HLA-A—psoriasis	9.74e-05	0.000243	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—NFKB1—psoriasis	9.66e-05	0.000241	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—NFKB1—psoriasis	9.66e-05	0.000241	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-DRB1—psoriasis	9.64e-05	0.00024	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-DRB1—psoriasis	9.64e-05	0.00024	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	9.62e-05	0.00024	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ICAM1—psoriasis	9.57e-05	0.000239	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PPARG—psoriasis	9.52e-05	0.000237	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—APOE—psoriasis	9.51e-05	0.000237	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—LEP—psoriasis	9.51e-05	0.000237	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NFKBIA—psoriasis	9.49e-05	0.000237	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—APOE—psoriasis	9.4e-05	0.000235	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—LEP—psoriasis	9.39e-05	0.000234	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—APOE—psoriasis	9.39e-05	0.000234	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	9.32e-05	0.000233	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PPARG—psoriasis	9.26e-05	0.000231	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ICAM1—psoriasis	9.25e-05	0.000231	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ICAM1—psoriasis	9.25e-05	0.000231	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NFKBIA—psoriasis	9.18e-05	0.000229	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NFKBIA—psoriasis	9.18e-05	0.000229	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—APOE—psoriasis	9.1e-05	0.000227	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—APOE—psoriasis	9.1e-05	0.000227	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	8.94e-05	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SOCS1—psoriasis	8.92e-05	0.000223	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—LEP—psoriasis	8.88e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—APOE—psoriasis	8.88e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PPARG—psoriasis	8.87e-05	0.000221	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	8.86e-05	0.000221	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS2—psoriasis	8.76e-05	0.000219	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	8.75e-05	0.000218	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—LEP—psoriasis	8.74e-05	0.000218	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—APOE—psoriasis	8.74e-05	0.000218	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	8.74e-05	0.000218	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—psoriasis	8.68e-05	0.000217	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SOCS1—psoriasis	8.63e-05	0.000215	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SOCS1—psoriasis	8.63e-05	0.000215	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—APOE—psoriasis	8.63e-05	0.000215	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—TYK2—psoriasis	8.51e-05	0.000212	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS2—psoriasis	8.48e-05	0.000211	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS2—psoriasis	8.48e-05	0.000211	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	8.28e-05	0.000207	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—TYK2—psoriasis	8.23e-05	0.000205	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—TYK2—psoriasis	8.23e-05	0.000205	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	8.15e-05	0.000203	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	8.12e-05	0.000203	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TYK2—psoriasis	8.04e-05	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—psoriasis	7.92e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—APOE—psoriasis	7.88e-05	0.000196	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—TYK2—psoriasis	7.77e-05	0.000194	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—LEP—psoriasis	7.77e-05	0.000194	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—APOE—psoriasis	7.77e-05	0.000194	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CARM1—psoriasis	7.69e-05	0.000192	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—psoriasis	7.66e-05	0.000191	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—psoriasis	7.66e-05	0.000191	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—APOE—psoriasis	7.62e-05	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—APOE—psoriasis	7.62e-05	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—TYK2—psoriasis	7.52e-05	0.000188	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—TYK2—psoriasis	7.52e-05	0.000188	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PPARG—psoriasis	7.52e-05	0.000188	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CXCL8—psoriasis	7.41e-05	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNG—psoriasis	7.28e-05	0.000182	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TYK2—psoriasis	7.26e-05	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.24e-05	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—LEP—psoriasis	7.22e-05	0.00018	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—APOE—psoriasis	7.22e-05	0.00018	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TYK2—psoriasis	7.18e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TYK2—psoriasis	7.17e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CXCL8—psoriasis	7.17e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CXCL8—psoriasis	7.17e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNG—psoriasis	7.04e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNG—psoriasis	7.04e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD4—psoriasis	7.03e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	7e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TYK2—psoriasis	6.94e-05	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TYK2—psoriasis	6.94e-05	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PPARG—psoriasis	6.86e-05	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD4—psoriasis	6.8e-05	0.00017	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD4—psoriasis	6.8e-05	0.00017	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TYK2—psoriasis	6.78e-05	0.000169	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	6.72e-05	0.000168	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TYK2—psoriasis	6.67e-05	0.000166	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—psoriasis	6.66e-05	0.000166	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PPARG—psoriasis	6.64e-05	0.000166	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PPARG—psoriasis	6.64e-05	0.000166	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—APOE—psoriasis	6.58e-05	0.000164	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—LEP—psoriasis	6.58e-05	0.000164	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—psoriasis	6.53e-05	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—JUN—psoriasis	6.51e-05	0.000162	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD4—psoriasis	6.49e-05	0.000162	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—LEP—psoriasis	6.37e-05	0.000159	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOE—psoriasis	6.37e-05	0.000159	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LEP—psoriasis	6.37e-05	0.000159	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOE—psoriasis	6.37e-05	0.000159	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	6.32e-05	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—psoriasis	6.31e-05	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—psoriasis	6.31e-05	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—JUN—psoriasis	6.29e-05	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD4—psoriasis	6.28e-05	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD4—psoriasis	6.28e-05	0.000157	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	6.27e-05	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL8—psoriasis	6.24e-05	0.000156	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NFKBIA—psoriasis	6.14e-05	0.000153	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—JUN—psoriasis	6.09e-05	0.000152	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—JUN—psoriasis	6.09e-05	0.000152	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NFKB1—psoriasis	6.06e-05	0.000151	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—psoriasis	6.01e-05	0.00015	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NFKBIA—psoriasis	5.94e-05	0.000148	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NFKBIA—psoriasis	5.94e-05	0.000148	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—psoriasis	5.93e-05	0.000148	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TYK2—psoriasis	5.93e-05	0.000148	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	5.9e-05	0.000147	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—JUN—psoriasis	5.88e-05	0.000147	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NFKB1—psoriasis	5.86e-05	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NFKB1—psoriasis	5.86e-05	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	5.81e-05	0.000145	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—JUN—psoriasis	5.8e-05	0.000145	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	5.69e-05	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	5.66e-05	0.000141	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—STAT3—psoriasis	5.63e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—psoriasis	5.61e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NFKB1—psoriasis	5.58e-05	0.000139	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—psoriasis	5.53e-05	0.000138	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TYK2—psoriasis	5.51e-05	0.000137	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—JUN—psoriasis	5.49e-05	0.000137	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—STAT3—psoriasis	5.44e-05	0.000136	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—JUN—psoriasis	5.4e-05	0.000135	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	5.28e-05	0.000132	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—STAT3—psoriasis	5.27e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—STAT3—psoriasis	5.27e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	5.2e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.16e-05	0.000129	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	5.13e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—STAT3—psoriasis	5.08e-05	0.000127	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—psoriasis	5.07e-05	0.000126	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TYK2—psoriasis	5.03e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—STAT3—psoriasis	5.03e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—STAT3—psoriasis	5.02e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—psoriasis	4.91e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TYK2—psoriasis	4.86e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TYK2—psoriasis	4.86e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—STAT3—psoriasis	4.86e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—STAT3—psoriasis	4.86e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—JUN—psoriasis	4.8e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	4.8e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	4.8e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—psoriasis	4.75e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAT—psoriasis	4.73e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	4.72e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—psoriasis	4.67e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.62e-05	0.000115	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—psoriasis	4.56e-05	0.000114	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—JUN—psoriasis	4.46e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—psoriasis	4.38e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—psoriasis	4.3e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	4.29e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—psoriasis	4.23e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—psoriasis	4.23e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.19e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—psoriasis	4.16e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.15e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—JUN—psoriasis	4.07e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—psoriasis	4.03e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—psoriasis	4.03e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JUN—psoriasis	3.94e-05	9.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JUN—psoriasis	3.94e-05	9.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—psoriasis	3.93e-05	9.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NFKB1—psoriasis	3.92e-05	9.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	3.9e-05	9.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—psoriasis	3.88e-05	9.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—psoriasis	3.86e-05	9.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—psoriasis	3.83e-05	9.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—psoriasis	3.8e-05	9.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NFKB1—psoriasis	3.79e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NFKB1—psoriasis	3.79e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—psoriasis	3.68e-05	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—psoriasis	3.68e-05	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOE—psoriasis	3.68e-05	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—psoriasis	3.62e-05	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—psoriasis	3.57e-05	8.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—psoriasis	3.55e-05	8.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—psoriasis	3.55e-05	8.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—psoriasis	3.52e-05	8.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—psoriasis	3.51e-05	8.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—psoriasis	3.51e-05	8.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—psoriasis	3.44e-05	8.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—psoriasis	3.44e-05	8.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—psoriasis	3.4e-05	8.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—psoriasis	3.4e-05	8.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—psoriasis	3.4e-05	8.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—psoriasis	3.4e-05	8.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—psoriasis	3.32e-05	8.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.26e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARG—psoriasis	3.2e-05	7.99e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.17e-05	7.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—psoriasis	2.94e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—psoriasis	2.9e-05	7.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—psoriasis	2.69e-05	6.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—psoriasis	2.69e-05	6.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—psoriasis	2.6e-05	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—psoriasis	2.6e-05	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—psoriasis	2.46e-05	6.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—psoriasis	2.38e-05	5.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—psoriasis	2.38e-05	5.93e-05	CbGpPWpGaD
